Home
>
National Drug Code (NDC)
>
ABILIFY
ABILIFY - 16590-745-30 - (ARIPIPRAZOLE)
Drug Information of ABILIFY
| Product NDC: | 16590-745 |
| Proprietary Name: | ABILIFY |
| Non Proprietary Name: | ARIPIPRAZOLE |
| Active Ingredient(s): | 5 mg/1 & nbsp; ARIPIPRAZOLE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ABILIFY
| Product NDC: | 16590-745 |
| Labeler Name: | STAT RX USA LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021436 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20021115 |
Package Information of ABILIFY
| Package NDC: | 16590-745-30 |
| Package Description: | 30 TABLET in 1 BOTTLE, PLASTIC (16590-745-30) |
NDC Information of ABILIFY
| NDC Code | 16590-745-30 |
| Proprietary Name | ABILIFY |
| Package Description | 30 TABLET in 1 BOTTLE, PLASTIC (16590-745-30) |
| Product NDC | 16590-745 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ARIPIPRAZOLE |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20021115 |
| Marketing Category Name | NDA |
| Labeler Name | STAT RX USA LLC |
| Substance Name | ARIPIPRAZOLE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Atypical Antipsychotic [EPC] |
